NOS1 and Parkinson disease: In this context, docosahexaenoic acid, a compound able to phosphorylate nNOS and therefore reduce its activity, has been shown to be protective against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity in dopaminergic neurons in animal models of PD [32].